These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 2053145

  • 1. Single center experience of the effect of delayed function on outcome in retransplant recipients of cadaveric renal allografts.
    Langley J, Vergne-Marini P, Dickerman RM, Brinker KR, Land G.
    Transplant Proc; 1991 Apr; 23(2):1757-9. PubMed ID: 2053145
    [Abstract] [Full Text] [Related]

  • 2. Effect of sequential Minnesota-antilymphocyte globulin and cyclosporine therapy in primary cadaveric renal transplant recipients with delayed graft function.
    Venkat KK, Kupin W, Oh HK.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1544-5. PubMed ID: 2652499
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A multi-factor analysis of kidney regraft outcomes.
    Gjertson DW.
    Clin Transpl; 2002 Feb; ():335-49. PubMed ID: 12971460
    [Abstract] [Full Text] [Related]

  • 6. An analysis of predictors of long-term cadaveric renal allograft survival.
    Cole E, Naimark D, Aprile M, Wade J, Cattran D, Pei Y, Fenton S, Robinette M, Zaltsman J, Bear R.
    Clin Transplant; 1995 Aug; 9(4):282-8. PubMed ID: 7579734
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.
    Sumrani N, Hong JH, DiBenedetto A, Clayton R, Miles AM, Markell MS, Distant DA, Fleishhacker J, Sommer BG.
    Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [4-way immunosuppression in pre-sensitized recipients of allogenic cadaver kidney transplants].
    Oesterwitz H, May G, Müller P, Strobelt V, Seeger W, Seibt F, Horlbeck R, Hansen C.
    Z Urol Nephrol; 1990 Jan; 83(1):1-8. PubMed ID: 2184625
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Is sequential low-dose immunotherapy the preferred treatment in cadaveric renal transplantation?
    Posner MP, Mendez-Picon G, King A, Nelson KP, Spicer HG, Lee HM.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1594-7. PubMed ID: 2652519
    [No Abstract] [Full Text] [Related]

  • 17. Frequency and severity of acute rejection in live- versus cadaveric-donor renal transplants.
    Campbell SB, Hothersall E, Preston J, Brown AM, Hawley CM, Wall D, Griffin AD, Isbel NM, Nicol DL, Johnson DW.
    Transplantation; 2003 Nov 27; 76(10):1452-7. PubMed ID: 14657685
    [Abstract] [Full Text] [Related]

  • 18. Early function as the principal correlate of graft survival. A multivariate analysis of 200 cadaveric renal transplants treated with a protocol incorporating antilymphocyte globulin and cyclosporine.
    Halloran PF, Aprile MA, Farewell V, Ludwin D, Smith EK, Tsai SY, Bear RA, Cole EH, Fenton SS, Cattran DC.
    Transplantation; 1988 Aug 27; 46(2):223-8. PubMed ID: 3043779
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Graft outcome in cadaver renal transplants treated with full-dose cyclosporine induction without antibody, irrespective of graft function.
    Douzdjian V, Bhaskar S, Baliga PK, Rajagopalan PR.
    Clin Transplant; 1997 Aug 27; 11(4):294-8. PubMed ID: 9267718
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.